EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Comparison of oral morbidity and mid‐term efficacy of anterior urethroplasty using an autologous tissue‐engineered graft (MukoCell®) versus native oral mucosa graft

Leonidas Karapanos iD, Vincent Knorr, Luisa Halbe, Maximilian Schmautz, Bobirjon Ergashev, Axel Heidenreich iD

International Journal of Urology · 2023

DOI: 10.1111/iju.15247 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Urology, 2023. Verfasst von Leonidas Karapanos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Surgery, Faculty of Medicine and University Hospital Cologne, University of Co…. Hauptthemen laut MEDLINE: Urethral Stricture. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our study aimed to compare surgical success rate (SR) and oral morbidity of augmentation urethroplasty for anterior urethral strictures using autologous tissue‐engineered oral mucosa graft (TEOMG) named MukoCell® versus native oral mucosa graft (NOMG).

Methods

We conducted a single‐institution observational study on patients undergoing TEOMG and NOMG urethroplasty for anterior urethral strictures >2 cm in length from January 2016 to July 2020. SR, oral morbidity, and potential risk factors of recurrence were compared between groups were analyzed. A decrease of maximum uroflow rate < 15 mL/s or further instrumentation was considered a failure.

Results

Overall, TEOMG ( n = 77) and NOMG ( n = 76) groups had comparable SR (68.8% vs. 78.9%, p = 0.155) after a median follow‐up of 52 (interquartile range [IQR] 45–60) months for TEOMG and 53.5 (IQR 43–58) months for NOMG. Subgroup analysis revealed comparable SR according to surgical technique, stricture localization, and length. Only following repetitive urethral dilatations, TEOMG achieved lower SR (31.3% vs. 81.3%, p = 0.003). Surgical time was significantly shorter by TEOMG use (median 104 vs. 182 min, p < 0.001). Oral morbidity and the associated “burden” in patients' quality of life were significantly less at 3 weeks following the biopsy required for TEOMG manufacture, compared to NOMG harvesting and totally absent at 6 and 12 months postoperatively.

Conclusions

The SR of TEOMG urethroplasty appeared to be comparable to NOMG at a mid‐term follow‐up but taking into account the uneven distribution of stricture site and the surgical techniques used in both groups. Surgical time was significantly shortened, since no intraoperative mucosa harvesting was required, and oral complications were diminished through the preoperative biopsy for MukoCell® manufacture.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urethral StrictureMaleHumansConstriction, PathologicMouth MucosaQuality of LifeTreatment OutcomeUrologic Surgical Procedures, MaleUrethraRetrospective Studies

Stichwörter der Autor:innen

anterior urethral strictureaugmentation urethroplastyautologous graft transplantationoral mucosa grafttissue engineering

Autor:innen und Institutionen

  • Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Department of Urology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Department of Urology, Andijan State Medical Institute, Andijan, Uzbekistan.

ORCID-Profile: Leonidas Karapanos, Axel Heidenreich

Zitieren

APA

Karapanos, L., Knorr, V., Halbe, L., Schmautz, M., Ergashev, B., & Heidenreich, A. (2023). Comparison of oral morbidity and mid‐term efficacy of anterior urethroplasty using an autologous tissue‐engineered graft (MukoCell®) versus native oral mucosa graft. International Journal of Urology. https://doi.org/10.1111/iju.15247

Vancouver

Karapanos L, Knorr V, Halbe L, Schmautz M, Ergashev B, Heidenreich A. Comparison of oral morbidity and mid‐term efficacy of anterior urethroplasty using an autologous tissue‐engineered graft (MukoCell®) versus native oral mucosa graft. International Journal of Urology. 2023. doi:10.1111/iju.15247

BibTeX
@article{Karapanos2023,
  author = {Karapanos, Leonidas and Knorr, Vincent and Halbe, Luisa and Schmautz, Maximilian and Ergashev, Bobirjon and Heidenreich, Axel},
  title = {Comparison of oral morbidity and mid‐term efficacy of anterior urethroplasty using an autologous tissue‐engineered graft (MukoCell®) versus native oral mucosa graft},
  journal = {International Journal of Urology},
  year = {2023},
  doi = {10.1111/iju.15247}
}
Kostenlos starten →